Page last updated: 2024-08-22

camptothecin and Breast Cancer, Male

camptothecin has been researched along with Breast Cancer, Male in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abramson, V; Bardia, A; Berlin, J; Diamond, JR; Goldenberg, DM; Govindan, SV; Guarino, M; Isakoff, SJ; Juric, D; Kalinsky, K; Maliakal, P; Mayer, IA; Messersmith, WA; Moroose, RL; O'Shaughnessy, J; Ocean, AJ; Shah, NC; Sharkey, RM; Starodub, AN; Tolaney, SM; Vahdat, LT; Wegener, WA	1

Trials

1 trial(s) available for camptothecin and Breast Cancer, Male

Article	Year
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jul-01, Volume: 35, Issue:19 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms, Male; Camptothecin; Cell Adhesion Molecules; Female; Humans; Immunoconjugates; Male; Middle Aged; Neoplasm Metastasis; Triple Negative Breast Neoplasms	2017

Article

Year

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jul-01, Volume: 35, Issue:19

Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms, Male; Camptothecin; Cell Adhesion Molecules; Female; Humans; Immunoconjugates; Male; Middle Aged; Neoplasm Metastasis; Triple Negative Breast Neoplasms

2017